TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
ASND

Ascendis Pharma AS

Healthcare · Biotechnology

275.40$ +3.1% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Ascendis Pharma AS (ASND)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.8% of the shares are freely tradable; institutional investors hold 103.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 103.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 5.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 66Mio.

Largest Shareholders

Institutions

Institutions ASND
Name Stake (%) Shares Change (%) Date
Frazier Life Sciences Management, L.P. 0.34 225,155 +68.9 06/30/2026
Neuberger Berman Group LLC 0.22 142,705 +0.0 06/30/2026
ODDO BHF Asset Management SAS 0.20 128,657 +0.0 06/30/2026
Quadrature Capital Limited 0.06 40,845 +0.0 06/30/2026

Funds

Funds ASND
Name Stake (%) Shares Change (%) Date
Janus Henderson Hrzn Biotec E2 USD 0.35 228,416 +0.0 03/31/2026
Spyglass US Growth F USD Inc 0.11 69,317 -0.9 03/31/2026
Invesco NASDAQ Next Gen 100 ETF 0.05 29,931 +0.5 04/20/2026
Russell Inv Tax-Managed US Mid&Sm Cap S 0.02 15,611 +0.0 09/30/2026
First Trust Long/Short Equity ETF 0.02 15,461 +0.0 04/20/2026
Rhenman Healthcare Equity L/S RC2 SEK 0.02 15,000 +0.0 01/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ASND
Person Role Shares Value As of Type
Holtug Lars Director 4,000 1,101,600 $ Sep 2, 2026 direct
Bienaime Jean Jacques Director 2,900 798,660 $ Aug 14, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 8, 2026 Bodenhoff Mads SVP & PAO Sell 3,000 270.19 810,570
Sep 8, 2026 Bodenhoff Mads SVP & PAO Other 3,000 110.00 330,000
Sep 2, 2026 Holtug Lars Director Sell 236 264.13 62,335
Aug 14, 2026 Bienaime Jean Jacques Director Buy 900 246.91 222,219
Aug 14, 2026 Bienaime Jean Jacques Director Buy 1,100 245.85 270,435

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?